Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569374 · ClinicalTrials.gov registry record · Phase 2
Safety and Tolerability of Modafinil for Methamphetamine Dependence
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00569374 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 8 participants.
The verdict
NCT00569374, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00569374
The ClinicalTrials.gov registry entry for NCT00569374 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00569374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00569374 about?
NCT00569374 is a clinical study titled "Safety and Tolerability of Modafinil for Methamphetamine Dependence". This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
What is the current status of trial NCT00569374?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2007-09.
What interventions are being tested in trial NCT00569374?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00569374?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.